Potential remuneration models for medication review with follow-up service in community pharmacy
- Publication Type:
- Journal Article
- Pharmaceutical Care Espana, 2015, 17 (4), pp. 423 - 441
- Issue Date:
Introduction: Different reasons justify the need to remunerate the provision of the service of Medication Review with follow-up (MRF). Its price could be obtained through several calculations and its value is essential to sustain the activity. Objective: To explore how is being justified the need to remunerate the MRF' provision, to describe the proposals on who should pay and to whom, as well as to explore the models of remuneration proposed. Method: 21 semi-structured interviews were conducted with innovative pharmacists experienced in the provision of MRF service and with others that have just been introduced to it within the framework of the conSIGUE program. Results: Pharmacists justified the need to obtain the remuneration of the service for different reasons. In both groups, it is argued that the pharmacist possesses the expertise to provide the service and is surpassed by an easy access to patients. In addition to this, participants referred to the assumption of responsibility and to the economic and clinical impact of the service provision. In both groups the Administration is proposed as the main payer while it is recommended to pay to the pharmacy as an organization as well as, to economically and professionally compensate the provider. The price must cover between others, costs of provision and the spent time. It could be also considered the complexity of the case, the impact and efficiency, the number of patients, etc. Conclusion: It is necessary to obtain the remuneration of MRF's service with a suitable price in order to sustain the activity. This type of service must be defrayed by the Administration without ruling a patient copayment. The community pharmacy must bill the service provision and the provider must be compensated.
Please use this identifier to cite or link to this item: